引用本文:王东侠 1,刘金秋 1,夏云龙 1,谭茗月 2.重组人促红细胞生成素对压力超负荷大鼠左室肥厚的抑制作用[J].大连医科大学学报,2015,37(3):227-231.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
重组人促红细胞生成素对压力超负荷大鼠左室肥厚的抑制作用
王东侠 1,刘金秋 1,夏云龙 1,谭茗月 21,2
1.大连医科大学附属第一医院 心内科,辽宁 大连 116011;2.中南大学湘雅二医院 心内科,湖南 长沙 410000
摘要:
[摘要] 目的 探讨重组人促红细胞生成素(rhEPO)对压力超负荷大鼠心室肥厚的干预作用及机制。 方法 通过腹主动脉缩窄法建立大鼠压力超负荷诱导的心室肥厚模型后,将大鼠随机分为假手术组(Sham组),模型组(AAC组),rhEPO干预组(rhEPO组),4周后处死大鼠,计算左室质量指数,心肌常规HE染色观察心室肌病理变化,分别用黄嘌啉氧化酶法、比色法检测心肌中丙二醛(MDA)、超氧化物歧化酶(SOD)含量。用双夹心ELISA法测定心室组织的肿瘤坏死因子-α(TNF-α)含量,比较各组差异。 结果 4周后AAC组大鼠心肌显示明显的心肌肥厚,心室质量指数、MDA以及TNF-α的含量与Sham组大鼠比较均明显增高,而SOD的含量显著降低(P<0.01)。rhEPO干预后大鼠未显示明显的心肌肥厚,与AAC组大鼠相比,心室质量指数、MDA以及TNF-a的含量明显降低,SOD的含量则增高(P<0.01)。 结论 rhEPO可以抑制压力超负荷诱导的心室肥厚的形成,其部分机制可能与其抑制心肌中的过氧化反应及抗炎效应有关。
关键词:  心室肥厚  压力超负荷  氧化应激  炎症  促红细胞生成素
DOI:10.11724/jdmu.2015.03.05
分类号:
基金项目:
Effect of rhEPO on left ventricular hypertrophy induced by pressure-overload
WANG Dong-xia 1, LIU Jin-qiu 1, XIA Yun-long 1,TAN Ming-yue 21,2
1.Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China;2.Department of Cardiology,Second Xiangya Hospital,Central South University,Changsha 410000,China
Abstract:
[Abstract] Objective To investigate the effect of rhEPO on left ventricular hypertrophy induced by pressure-overload in rats. Methods The rat model were established by coarctation of abdominal aorta (AAC) in Wister rats. Rats were randomly allocated to three groups: Sham group, AAC group, rhEPO group. Rats in rhEPO group were injected rhEPO (1000 U/kg) subcutaneously for three times a week after operation. Rats in Sham group were given the same volume of physiological saline. All rats were killed after 4 weeks. Left ventricular mass index (LVMI) was calculated. Myocardial histological changes were observed with routine HE stain, and the level of SOD, MDA, TNF-α in myocardium were detected respectively. Results Compared with the sham group, there were significant cardiac hypertrophy, higher LVWI and level of MDA and TNF-α (P<0.01), while lower SOD level (P<0.01) in myocardium in rats of AAC group. However, compared with the AAC group, cardiac hypertrophy was significantly relieved in rhEPO group, as well as LVMI and the levels of MDA, TNF-α decreased, SOD level improved in myocardium (P<0.01). Conclusion RhEPO could attenuates left ventricular hypertrophy induced pressure overload via its function of antioxidation and anti-inflammatory.
Key words:  [Key words] ventricular hypertrophy  pressure overload  oxidative stress  inflammation  erythropoietin